HN user

muditjai

1 karma

Currently Co-founder and CTO at a stealth AI company. Previously - Tech lead at Google Deepmind. - Head of engineering of a medical AI company which was acquired by Nvidia. - Tech lead in GCP AutoML NLP team. - Microsoft speech and query rewriting teams.

Posts0
Comments2
View on HN
No posts found.

Thanks for the great summary. But I'm guessing previous immunotherapy based treatments are also based on stimulating T-cells to fight cancer cells. Any idea why they didn't work? This method only makes it easy to stimulate T-cells, but what about mutations in cancer.